EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS139-12389 
Organism
Homo sapiens 
Tissue/cell
Myotube 
Coordinate
chr12:50938430-50941470 
TF binding sites/motifs
Number: 26             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr12:50939112-50939130CCCTCCCTCCCTCCCTCC-6.03
EWSR1-FLI1MA0149.1chr12:50939136-50939154CTTTCTTCCTTTCCTTCC-6.06
EWSR1-FLI1MA0149.1chr12:50939093-50939111CCTCCCTTCCTCCCTTCA-6.66
EWSR1-FLI1MA0149.1chr12:50939097-50939115CCTTCCTCCCTTCATCCC-6.88
EWSR1-FLI1MA0149.1chr12:50939089-50939107TCTTCCTCCCTTCCTCCC-7.45
NEUROG2MA0669.1chr12:50940257-50940267GACATATGTT-6.02
Nr2f6(var.2)MA0728.1chr12:50939637-50939652TGAACTCCTGACCTC-6.22
STAT3MA0144.2chr12:50941034-50941045TTTCTGGGAAG+6.02
ZNF263MA0528.1chr12:50939093-50939114CCTCCCTTCCTCCCTTCATCC-6.02
ZNF263MA0528.1chr12:50939136-50939157CTTTCTTCCTTTCCTTCCTCT-6.07
ZNF263MA0528.1chr12:50939151-50939172TCCTCTCCCCTCCTCTCCCCT-6.08
ZNF263MA0528.1chr12:50939115-50939136TCCCTCCCTCCCTCCTTCTTT-6.11
ZNF263MA0528.1chr12:50939146-50939167TTCCTTCCTCTCCCCTCCTCT-6.12
ZNF263MA0528.1chr12:50939088-50939109CTCTTCCTCCCTTCCTCCCTT-6.14
ZNF263MA0528.1chr12:50939163-50939184CTCTCCCCTCCCTCCCCCTCC-6.19
ZNF263MA0528.1chr12:50939096-50939117CCCTTCCTCCCTTCATCCCTC-6.36
ZNF263MA0528.1chr12:50939139-50939160TCTTCCTTTCCTTCCTCTCCC-6.41
ZNF263MA0528.1chr12:50939104-50939125CCCTTCATCCCTCCCTCCCTC-6.59
ZNF263MA0528.1chr12:50939100-50939121TCCTCCCTTCATCCCTCCCTC-6.61
ZNF263MA0528.1chr12:50939108-50939129TCATCCCTCCCTCCCTCCCTC-6.72
ZNF263MA0528.1chr12:50939156-50939177TCCCCTCCTCTCCCCTCCCTC-6.88
ZNF263MA0528.1chr12:50940511-50940532AGAGGAGGGACGAGGAGGGAG+6
ZNF263MA0528.1chr12:50939166-50939187TCCCCTCCCTCCCCCTCCCCT-7.53
ZNF263MA0528.1chr12:50939160-50939181CTCCTCTCCCCTCCCTCCCCC-7.74
ZNF263MA0528.1chr12:50939112-50939133CCCTCCCTCCCTCCCTCCTTC-8.94
ZfxMA0146.2chr12:50939662-50939676CCCGCCTCGGCCTC+6.01
Number of super-enhancer constituents: 2             
IDCoordinateTissue/cell
SE_60244chr12:50898229-50941277Ly4
SE_64405chr12:50939466-50940947NHEK
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr125093978450940089
chr125093913750939453
Number: 1             
IDChromosomeStartEnd
GH12I050545chr125093919350941014
Enhancer Sequence
GAGTCTGTCA CCCAGGCTGG AGTGCAATGG CGTGATCTCA GTTCACTGCA ACCTCCACTT 60
CCCAGGTTCA AGCAATTCTC CTGCCTCAGC CTCCTGAGTA GTTGGGACTA CAGGTGCGTG 120
CCACCACGCC CGGCTAATTT TTTGTATTTT TAGTAGAGAA GGGGTTCCAC TGTGTTAGCC 180
AGGCTGATCT CGAACTCCTG ACCTCATGAT CTGCCCGCCT TGGCCTCCCA AAGTGCTGGG 240
ATTACAGGCG TGAGCCACCG CGCCTGGCTG AATAACTTTC TTAAAAGCTG GAGTAGTACC 300
AGGTGTGGTT TCTTATGACT GTAATACTAG CACTTTGGGA GGCCAAGATG GGAGAATCAC 360
TTGAGCCCAG GAGTTCAAGA CCAGCTTGTA TGACTGTACC ACATTCATTT ATTCTATTGT 420
TGGTGAGCAT TTGGTTTGTT TCCAGTTTTG GCTTTTGCGA ATGTTTTGTA TATGTTTTGT 480
GGTGCCCATA TTTTAGATAA AATTACTAGT AGTGGAATTG CTTGGTCTTA GGGTATGCGA 540
ATGTTCAGCT TCAGTGGTAT TACCAGTTTT CCAAAGTGTT TATACCGATT TACAGACCTT 600
TTGGCAACGT ATGAGAGTTC CATTTCTTCC TGTACTTACC AATACTTGCT TGCTTGCTCT 660
CTTCCTCCCT TCCTCCCTTC ATCCCTCCCT CCCTCCCTCC TTCTTTCTTT CTTCCTTTCC 720
TTCCTCTCCC CTCCTCTCCC CTCCCTCCCC CTCCCCTCCG TTCTGTCACC CAGCCTAGAG 780
TGCAGTGGCG CCATCACAGC TCACTACAGC CTTGACTTCT TGAGCTCAAG TGATCATCTC 840
ACCCCAGCCT CCCGAGTAGC TGGGACTACA GGCATGTGCC ACCATGCCTG GCTAATTAAA 900
AAAAATTTTT TTACAGATAG TGTCTTGCCA TGTTGGCCAG GCTGGTCTTG AGCTCCTCTG 960
CTGAAGATAA CATTTTGGGC CAGGCATGGT TACTCACACC TGTAACTTTT ATTTTTTGGA 1020
GGCAGACTTT TTTTTTTTTT TTTCATAACG CTATCTGGGC TCACTGCAAC CTCTGCCTCC 1080
TGGGTTCTAG TGATTCTCCT GCCTCTGACT CCCAAGTAGC TGAGATTACA GGCGTGTGCC 1140
ACCGTGCCCA GCTAGTTTTT TGTATTTTTA GTAGAGGCGG GGTTTCACCA TGTTGGCCAG 1200
CTGGTCTTGA ACTCCTGACC TCAAGTGATC CACCCGCCTC GGCCTCTCAA AGTGTGGGAT 1260
TATAGCTGTG AGTCACTGTG CCCGGCCTAA AATAAGATTT ATTGAGGACT TGTGTATAGC 1320
ATGGTAGAAA TAAAAGCAGA ATTCCTTCTC TTCATTTTAC AGTTCTTTCT GTGGAAATGA 1380
GTACAACTGA ATATAGCAGG TGGCAGTGCC TGTCAACTTT GTTTCCATTC TGCACTGATT 1440
GTATTATCTT ATTCTAATCC CTGCCAACCA GATGTACTTC CTTCTTCACA TAAGATGGAG 1500
ACAGCTTATT GTATATGCAC ACATGTGCAA ATATGCATAA GTATAGCAAA AGTTGGTCCT 1560
GCTGTTCAGA AATATCGTTA ACTAGTATCA AGTGAGAGGC GGCATGGTTT ACTTCAGGTA 1620
CAGCATATAG TTTTAGATGC TTATTCCTCC CCTGTTGGTG GGAGTTCCGT GTTGTGAAAA 1680
ATTCTTTTTT AAAAAAATTT CAACTTTTAT TTTAGGTTCA GGGGGTACAT GTAAATGTTT 1740
GTTACATGAG TTGTGAAGAA TTCTGAGGCC ATGCCTGAGA TCAGTGATTC AGAAGTCCTG 1800
TCACTGAATA GTAATTGTTG CAGGGGTGAC ATATGTTCCA CATATTTACC TTCTGTAAGT 1860
GAAGCAGAGT GAAGAACCAG ACCAATGTAG ATTTTCTAGC ACTTATTTTT GGGCAAGTTA 1920
TTTTGTTCTC TGGGCCTCTC AATGTCCTTA TCTGGAAAAT AGGAGGTCAC ATTCTTGCTA 1980
GGATTAAATA CATTAATGCA TGCAAAGTAT TTCCTGATTG CCTTGCAGAT AGATAATAGG 2040
TGCCCAGTAA ATGTTAGTTC TGTCCCTTTT TTTTGTATGG GAGAGGAGGG ACGAGGAGGG 2100
AGTGGGCTGT TCTTAAATAG GAATATTTTT AAAACGTATT ATGAACTTAT CACAGCCCCA 2160
TGTTTCACTT TTCAGGGCCA ATGTAGGAGG CAGTAAAGAA AGAAAAATAA ATGAGACATC 2220
TCTTGTCAAG TTATAACTGG TTTTATGTAT AAATAATTTA GAAACACATT ACCTATAATA 2280
CAAAACAATT AAAAAATATA CCACTCTATT TGGCTGTATT TACTACTTTT CTGAAACTGC 2340
TTACTCGGAG GTTCGGTTCA CCTTACCTCC TTATTTTTAC TCCCTTCTTT TTTGACCTTC 2400
GTGGTACTAT TAACCACCAA CTTTGGTGAA ATCCTTTCTT TCCTTGGCTT CAGTGAAAAC 2460
ATCACTTTCT AAACAATGAA TTTCGTTTTC TACTGGACAG GGGCCCTTTA TATAGAGGCA 2520
ATAAACTTGT ATGTTTAACT TTGATGATTG ATTATTGATT CAGTTGGTAA TACAAATTAA 2580
AGTTTGGCTT AAAACAGTGA AATATTTCTG GGAAGTAATT GAATGATGAC TGTACAACAC 2640
TAGAGTAATT TAAAAATACT TAGTGGAAAT ATTCATTGAT ACCATCTTTT TTTAGAAGCT 2700
AATTTAACAG TAACTCAAAG CAGGGTTAAT TTTGTGTAAC CTGGCACCCA ACATTATATG 2760
TCTAGGAATC TGTCCCTCAA TAGGATGAAT GGTAAAAACA TATGTAGAGA GATATTAATC 2820
GAAGTATTAT TTGTAAGAAC AAAAGATGGA AACAACTTAA ACACTTGTCA ATAGAAAAAT 2880
AGTGAAATTA TGATTTATTC TTACTATTCT TCCGTTAAAA AAGTGAGCTA GAGTGTGTGG 2940
GGGCAGAGTG TATGAGAGAA ATCTCTGTAC CTTCTGTTCA ATTTTGCTGT GAACCTAAAA 3000
CTGCTAAAAA AAATAAGTCT ACTAAAAGAG CTAGAGCTAT 3040